BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/14/2026 3:57:26 AM | Browse: 5 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic factors and optimal timing for initiating adjuvant chemotherapy in stage IIIC gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun-Wei Wu, Fan Li, Shi-Dian Wang, Yu-Kun Guo, Bing-Huang Li, Xin Zhou, Guo-Qiang Su and Chuan-Hui Lu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 81970462 |
| Key Medical and Health Project of Xiamen |
No. 3502Z20204001 |
|
| Corresponding Author |
Chuan-Hui Lu, /, The Graduate School of Fujian Medical University, No. 1 Xuefu North Road, Shangjie Town, Minhou County, Fuzhou 350122, Fujian Province, China. 46601533@qq.com |
| Key Words |
Gastric cancer; Chemotherapy; Disease-free survival; Prognosis; Time factors |
| Core Tip |
We identified age ≥ 60 years, carcinoembryonic antigen ≥ 5.0 μg/L, metastatic lymph node ratio ≥ 0.5 and time interval (TI) from surgery to initiation of adjuvant chemotherapy are independent risk factors for postoperative recurrence. Crucially, our findings demonstrate that initiating adjuvant chemotherapy within 6 weeks of surgery significantly improves disease-free survival in stage IIIC patients. Notably, the S-1 plus oxaliplatin regimen exhibits significant time-sensitivity, with an optimal window of within 6 weeks. Whereas the capecitabine plus oxaliplatin regimen does not. These insights provide a rationale for optimizing individualized therapeutic strategies for this high-risk subgroup. |
| Citation |
Wu JW, Li F, Wang SD, Guo YK, Li BH, Zhou X, Su GQ, Lu CH. Prognostic factors and optimal timing for initiating adjuvant chemotherapy in stage IIIC gastric cancer. World J Gastrointest Oncol 2026; In press |
 |
Received |
|
2026-01-21 06:40 |
 |
Peer-Review Started |
|
2026-01-21 06:41 |
 |
First Decision by Editorial Office Director |
|
2026-01-27 07:56 |
 |
Return for Revision |
|
2026-01-27 11:39 |
 |
Revised |
|
2026-02-09 08:13 |
 |
Publication Fee Transferred |
|
2026-02-14 16:01 |
 |
Second Decision by Editor |
|
2026-04-14 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-14 03:57 |
 |
Articles in Press |
|
2026-04-14 03:57 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345